Search Results 1681-1690 of 17223 for hypercoagulable
ROCHESTER, Minn. — Mayo Clinic researchers have uncovered how aging "zombie cells" trigger harmful inflammation that accelerates a severe and increasingly ...
Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. Latest stories.
Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.
Learn about this complex operation that's used to treat pancreatic cancer and other digestive system conditions. Find out what to expect during recovery.
About this study. This is an open-label, multi-center, dose escalation study of REGN1979 administered as an IV (intravenous) infusion.
Mayo Clinic researchers are examining the effectiveness of a variety of precautions taken to reduce the risk of hemophiliac hemorrhage during surgeries. Mayo ...
ROCHESTER, Minn. — A team of Mayo Clinic researchers has developed an artificial intelligence (AI) system that can detect surgical site infections (SSIs) with ...
This is a multisite study to evaluate the safety, tolerability, and efficacy of LMN-201 in participants recently diagnosed with CDI who are scheduled to receive ...
ROCHESTER, Minn. — The American Heart Association and the Minnesota Department of Health recently recognized Mayo Clinic in Rochester as a Heart Safe ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.